Pheiron

Pheiron is an applied AI lab focused on engineering biological alpha — the ability to predict which biology will succeed in humans early enough to change the outcome of a drug program. The company builds AI systems that underwrite biology risk against clinical outcomes, using multimodal human data and clinical records to select and develop drug programs with the highest probability of success. Pheiron publishes public predictions on upcoming clinical readouts to validate its models, with the goal of dramatically reducing clinical-stage failures and increasing drug-per-dollar output for the industry.